BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26799259)

  • 21. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?
    Panigrahi B; Roman SA; Sosa JA
    Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
    Linder R; Fuhrmann J; Hammerschmidt D
    Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
    Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
    Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer.
    Kandil E; Gilson MM; Alabbas HH; Tufaro AP; Dackiw A; Tufano RP
    Ann Surg Oncol; 2011 Apr; 18(4):1028-34. PubMed ID: 21046269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medullary thyroid carcinoma: long-term outcomes of surgical treatment.
    Abraham DT; Low TH; Messina M; Jackson N; Gill A; Chou AS; Delbridge L; Learoyd D; Robinson BG; Sidhu S; Sywak M
    Ann Surg Oncol; 2011 Jan; 18(1):219-25. PubMed ID: 20878247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
    Siqueira DR; Romitti M; da Rocha AP; Ceolin L; Meotti C; Estivalet A; Puñales MK; Maia AL
    Endocr Relat Cancer; 2010 Dec; 17(4):953-63. PubMed ID: 20801952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.
    Valenciaga A; Grubbs EG; Porter K; Wakely PE; Williams MD; Cote GJ; Vasko VV; Saji M; Ringel MD
    Thyroid; 2017 Dec; 27(12):1523-1533. PubMed ID: 29105562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
    Esfandiari NH; Hughes DT; Yin H; Banerjee M; Haymart MR
    J Clin Endocrinol Metab; 2014 Feb; 99(2):448-54. PubMed ID: 24276457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long term prognosis of medullary thyroid carcinoma in 39 patients.
    Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
    Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of medullary thyroid cancer in RET carriers of ATA class A and C mutations.
    Machens A; Lorenz K; Dralle H
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E286-92. PubMed ID: 24297798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surgical management of medullary thyroid carcinoma. Personal experience].
    Geraci G; Pisello F; Tornambè A; Platia L; Sciumè C; Li Volsi F; Cupido F; Modica G
    G Chir; 2007 Oct; 28(10):385-9. PubMed ID: 17915054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medullary thyroid carcinoma.
    Pacini F; Castagna MG; Cipri C; Schlumberger M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].
    Zhao JQ; Guo L; Qi XP; Chen ZG; Wang KJ; Lou JL; Yu XH; Cheng J; Jin HY; Li XL; Ying RB; Zhang XN
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):440-4. PubMed ID: 23660264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India.
    Mehrotra PK; Mishra A; Mishra SK; Agarwal G; Agarwal A; Verma AK
    World J Surg; 2011 Jun; 35(6):1273-80. PubMed ID: 21479684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases.
    Beressi N; Campos JM; Beressi JP; Franc B; Niccoli-Sire P; Conte-Devolx B; Murat A; Caron P; Baldet L; Kraimps JL; Cohen R; Bigorgne JC; Chabre O; Lecomte P; Modigliani E
    Thyroid; 1998 Nov; 8(11):1039-44. PubMed ID: 9848720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
    Kotwal A; Erickson D; Geske JR; Hay ID; Castro MR
    Thyroid; 2021 Apr; 31(4):616-626. PubMed ID: 33108969
    [No Abstract]   [Full Text] [Related]  

  • 39. Current approaches to medullary thyroid carcinoma, sporadic and familial.
    Fialkowski EA; Moley JF
    J Surg Oncol; 2006 Dec; 94(8):737-47. PubMed ID: 17131404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medullary thyroid microcarcinoma: a population-level analysis of 310 patients.
    Kazaure HS; Roman SA; Sosa JA
    Cancer; 2012 Feb; 118(3):620-7. PubMed ID: 21717441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.